Study of Intravaginal Tamoxifen in PostMenopausal Women With VVA

NCT05378269 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

17

Enrollment

INDUSTRY

Sponsor class

Conditions

Vulvar Atrophy

Interventions

DRUG: Tamoxifen
OTHER: Placebo

Sponsor

Daré Bioscience, Inc.